1Division of Neurosurgery, Department of Surgery, University of British Columbia.
2Faculty of Medicine and the Division of Neurosurgery, University of British Columbia and British Columbia Children's Hospital; and.
J Neurosurg Pediatr. 2022 Feb 11;29(5):520-527. doi: 10.3171/2021.12.PEDS21539. Print 2022 May 1.
Holmes tremor (HT) is a rare and debilitating movement disorder comprising both rest and action tremor, and it is known for its resistance to treatment. Its most common causes include ischemic or hemorrhagic insults and trauma. Mechanistically, the combined rest and action tremor is thought to require a double lesion of both the dopaminergic nigrostriatal system and the dentatorubrothalamic pathways, often near the midbrain where both pathways converge. The aim of this study was to characterize HT as a presenting sign in cases of hydrocephalus and to discuss potential pathomechanisms, clinical presentations, and treatment options.
MEDLINE and Web of Science were searched for cases of HT with hydrocephalus from database inception to August 2021, and these were compiled along with the authors' own unique case of treatment-responsive HT in a child with low-pressure obstructive hydrocephalus secondary to a tectal tumor. Patient characteristics, presenting signs/symptoms, potential precipitating factors, interventions, and patient outcomes were recorded.
Nine patients were identified including the authors' video case report. All patients had a triventriculomegaly pattern with at least a component of obstructive hydrocephalus, and 4 patients were identified as having low-pressure hydrocephalus. Parinaud's syndrome and bradykinesia were the most commonly associated signs. Levodopa and CSF diversion were the most commonly used and effective treatments for HT in this population. This review was not registered and did not receive any funding.
HT is a poorly understood and probably underrecognized presentation of hydrocephalus that is difficult to treat, limiting the strength of the evidence in this review. Treatment options include CSF diversion, antiparkinsonian agents, antiepileptic agents, deep brain stimulation, and MR-guided focused ultrasound, and aim toward the nigrostriatal and dentatorubrothalamic pathways hypothesized to be involved in its pathophysiology.
霍姆斯震颤(HT)是一种罕见且使人虚弱的运动障碍,包括静止性震颤和动作性震颤,且以治疗抵抗而闻名。其最常见的病因包括缺血性或出血性损伤和创伤。从机制上讲,静止性震颤和动作性震颤的组合被认为需要多巴胺能黑质纹状体系统和齿状核红核束途径的双重病变,通常靠近中脑,两条途径在此交汇。本研究旨在将 HT 作为脑积水的首发表现进行特征描述,并讨论潜在的病理机制、临床表现和治疗选择。
从数据库建立到 2021 年 8 月,在 MEDLINE 和 Web of Science 上搜索与脑积水相关的 HT 病例,并将这些病例与作者自己治疗反应性 HT 的独特病例一起汇编,该病例为继发于脑顶盖肿瘤的低压梗阻性脑积水的儿童。记录患者特征、首发症状/体征、潜在诱发因素、干预措施和患者结局。
共确定了 9 例患者,包括作者的视频病例报告。所有患者均有三脑室扩大模式,至少存在部分梗阻性脑积水,4 例患者被确定为低压性脑积水。Parinaud 综合征和运动迟缓是最常见的相关体征。左旋多巴和 CSF 引流是该人群中治疗 HT 最常用和最有效的方法。本综述未注册,也未获得任何资金。
HT 是一种尚未被充分认识和理解的脑积水表现形式,且治疗困难,这限制了本综述中证据的强度。治疗选择包括 CSF 引流、抗帕金森病药物、抗癫痫药物、深部脑刺激和磁共振引导聚焦超声,这些治疗方法旨在针对被认为与 HT 病理生理学相关的黑质纹状体和齿状核红核束途径。